Old Web
English
Sign In
Acemap
>
Paper
>
Clonal Dynamics after Venetoclax-Obinutuzumab Therapy: Novel Insights from the Randomized, Phase 3 CLL14 Trial
Clonal Dynamics after Venetoclax-Obinutuzumab Therapy: Novel Insights from the Randomized, Phase 3 CLL14 Trial
2020
Othman Al-Sawaf
Can Zhang
Sandra Robrecht
Cameron Wilson
Maneesh Tandon
Travers Ching
Anna Maria Fink
Matthias Ritgen
Eugen Tausch
Karl Anton Kreuzer
William Schary
Clemens-Martin Wendtner
Barbara Eichhorst
Stephan Stilgenbauer
Yanwen Jiang
Michael Hallek
Kirsten Fischer
Keywords:
Obinutuzumab
Internal medicine
Medicine
Oncology
Venetoclax
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
14
Citations
NaN
KQI
[]